To evaluate effectiveness of Saruva thitha nirgundi thailam for the treatment of throat infection in children.

Phase 2

• Conditions: Health Condition 1: J039- Acute tonsillitis, unspecified

• Registration Number: CTRI/2024/06/069475
• Lead Sponsor: il

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Children with age group of 5 to 12 years of both sex.

Enlarged tonsils with Brodsky scale Grade 2 and above.

children also having at least three of the following symptoms:

1. Throat pain

2. Cough

3. Difficult to swallow

4. Fever

5. Halitosis

Exclusion Criteria

1. Pneumonia

2. Oral candidiasis

3. Tuberculosis

4. Peritonsillar abscess

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Efficacy of the trial drug will be assessed based on reduction in quantitative assessment scales of clinical symptoms. <br/ ><br>Enlargement of tonsils will be assessed by Brodsky scale. <br/ ><br>Throat pain will be assessed by VAS score. <br/ ><br>Cough severity will be assessed by VAS score. <br/ ><br>Dysphagia will be assessed based on Bazaz dysphagia scale. <br/ ><br>Halitposis will be assessed based on organoleptic score.Timepoint: Baseline at the time of enrolment - 0th day. <br/ ><br>First follow up - 7th day. <br/ ><br>Second follow up- 14th day. <br/ ><br>End point 28th day.

Secondary Outcome Measures

Name	Time	Method
ilTimepoint: Nil